Federal Register / Vol. 86, No. 38 / Monday, March 1, 2021 / Notices 12033 

SUMMARY: Groff NA Hemplex, LLC has 

applied to be registered as an importer 

of basic class(es) of controlled 

substance(s). Refer to Supplemental 

Information listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before March 31, 2021. Such persons 

may also file a written request for a 

hearing on the application on or before 

March 31, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing must 

be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All requests for a 

hearing should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/OALJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DPW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on January 19, 2021, Groff 

NA Hemplex, LLC, 100 Redco Avenue, 

Suite A, Red Lion, Pennsylvania 17356– 

1436, applied to be registered as an 

importer of the following basic class(es) 

of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Marihuana Extract ................... 7350 I 

Marihuana ............................... 7360 I 

Tetrahydrocannabinols ........... 7370 I 

The company plans to import finished 

dosage unit products containing 

Marihuana Extracts for clinical trial 

studies. These Marihuana Extracts 

compounds are listed under drug code 

7350. No other activity for this drug 

code is authorized for this registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

William T. McDermott, 

Assistant Administrator. 

[FR Doc. 2021–04181 Filed 2–26–21; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–799] 

Importer of Controlled Substances 

Application: Microgenics Corporation 

Thermo Fisher Scientific 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Microgenics Corporation 

Thermo Fisher Scientific has applied to 

be registered as an importer of basic 

class(es) of controlled substance(s). 

Refer to Supplemental Information 

listed below for further drug 

information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before March 31, 2021. Such persons 

may also file a written request for a 

hearing on the application on or before 

March 31, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing must 

be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All request for a hearing 

should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/OALJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DPW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on January 27, 2021, 

Microgenics Corporation Thermo Fisher 

Scientific, 46500 Kato Road Fremont, 

California 94538, has applied to be 

registered as an importer of the 

following basic classes of controlled 

substances: 

Controlled substance Drug code Schedule 

Cathinone ........................................................................................................................................................................ 1235 I 

Mephedrone (4-Methyl-N-methylcathinone) .................................................................................................................... 1248 I 

Gamma Hydroxybutyric Acid ........................................................................................................................................... 2010 I 

Methaqualone .................................................................................................................................................................. 2565 I 

Mecloqualone .................................................................................................................................................................. 2572 I 

2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3-methylbutanoate ............................................................................ 7021 I 

AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ......................................... 7023 I 

AB–CHMINACA (N-(1-amino-3-methyl-1-≤oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide ............... 7031 I 

MAB–CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ........ 7032 I 

5F–AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) .............................................. 7033 I 

ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ................................. 7035 I

APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide .............................................................. 7048 I 

AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ....................................................................................................... 7201 I 

Lysergic acid diethylamide .............................................................................................................................................. 7315 I 

Marihuana ........................................................................................................................................................................ 7360 I 

Tetrahydrocannabinols .................................................................................................................................................... 7370 I 

3,4-Methylenedioxyamphetamine .................................................................................................................................... 7400 I 

3,4-Methylenedioxy-N-ethylamphetamine ....................................................................................................................... 7404 I 

3,4-Methylenedioxymethamphetamine ............................................................................................................................ 7405 I 

2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C–I) ........................................................................................................ 7518 I 

MDPV (3,4-Methylenedioxypyrovalerone) ....................................................................................................................... 7535 I 

2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I–NBOMe) ......................................................... 7538 I 

Butylone ........................................................................................................................................................................... 7541 I 

Pentylone ......................................................................................................................................................................... 7542 I 

alpha-pyrrolidinopentiophenone (a-PVP) ........................................................................................................................ 7545 I 

Normorphine .................................................................................................................................................................... 9313 I 

12034 Federal Register / Vol. 86, No. 38 / Monday, March 1, 2021 / Notices 

Controlled substance Drug code Schedule 

AH–7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) .................................................................. 9551 I 

Acetylmethadol ................................................................................................................................................................ 9601 I 

Alphamethadol ................................................................................................................................................................. 9605 I 

Ketobemidone .................................................................................................................................................................. 9628 I 

Noracymethadol ............................................................................................................................................................... 9633 I 

Para-Fluorofentanyl ......................................................................................................................................................... 9812 I 

3-Methylfentanyl .............................................................................................................................................................. 9813 I 

Alpha-methylfentanyl ....................................................................................................................................................... 9814 I 

Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ............................................................................... 9821 I 

2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide ......................................................................................... 9825 I 

3-Methylthiofentanyl ......................................................................................................................................................... 9833 I 

Cyclopropyl Fentanyl ....................................................................................................................................................... 9845 I 

Fentanyl related-compounds as defined in 21 CFR 1308.11&h) ................................................................................... 9850 I 

Amphetamine ................................................................................................................................................................... 1100 II 

Methamphetamine ........................................................................................................................................................... 1105 II 

Methylphenidate .............................................................................................................................................................. 1724 II 

Amobarbital ...................................................................................................................................................................... 2125 II 

Pentobarbital .................................................................................................................................................................... 2270 II 

Secobarbital ..................................................................................................................................................................... 2315 II 

Phencyclidine ................................................................................................................................................................... 7471 II 

Cocaine ............................................................................................................................................................................ 9041 II 

Codeine ........................................................................................................................................................................... 9050 II 

Dihydrocodeine ................................................................................................................................................................ 9120 II 

Oxycodone ....................................................................................................................................................................... 9143 II 

Hydromorphone ............................................................................................................................................................... 9150 II 

Ecgonine .......................................................................................................................................................................... 9180 II 

Hydrocodone ................................................................................................................................................................... 9193 II 

Levorphanol ..................................................................................................................................................................... 9220 II 

Meperidine ....................................................................................................................................................................... 9230 II 

Meperidine intermediate-B .............................................................................................................................................. 9233 II 

Methadone ....................................................................................................................................................................... 9250 II 

Dextropropoxyphene, bulk (non-dosage forms) .............................................................................................................. 9273 II 

Morphine .......................................................................................................................................................................... 9300 II 

Thebaine .......................................................................................................................................................................... 9333 II 

Levo-alphacetylmethadol ................................................................................................................................................. 9648 II 

Oxymorphone .................................................................................................................................................................. 9652 II 

Carfentanil ....................................................................................................................................................................... 9743 II 

Tapentadol ....................................................................................................................................................................... 9780 II 

Fentanyl ........................................................................................................................................................................... 9801 II 

The company plans to import the 

listed controlled substances for 

feasibility studies for new products and 

cross reactivity studies for existing 

products. The products will serve as 

raw materials for In Vitro Diagnostic 

quantitative assay. No other activity for 

these drug codes is authorized for this 

registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of the Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

William T. McDermott, 

Assistant Administrator. 

[FR Doc. 2021–04147 Filed 2–26–21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–781] 

Bulk Manufacturer of Controlled 

Substances Application: Bulk 

Manufacturer of Marihuana: Cosmic 

Light LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: The Drug Enforcement 

Administration (DEA) is providing 

notice of an application it has received 

from an entity applying to be registered 

to manufacture in bulk basic class(es) of 

controlled substances listed in schedule 

I. DEA intends to evaluate this and other 

pending applications according to its 

regulations governing the program of 

growing marihuana for scientific and 

medical research under DEA 

registration. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefor, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before April 30, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. To ensure proper handling of 

comments, please reference Docket No– 

DEA–XXX in all correspondence, 

including attachments. 

SUPPLEMENTARY INFORMATION: The 

Controlled Substances Act (CSA) 

prohibits the cultivation and 

distribution of marihuana except by 

persons who are registered under the 

CSA to do so for lawful purposes. In 

accordance with the purposes specified 

in 21 CFR 1301.33(a), DEA is providing 

notice that the entity identified below 

has applied for registration as a bulk 

manufacturer of schedule I controlled 

substances. In response, registered bulk 

manufacturers of the affected basic 

class(es), and applicants therefor, may 

file written comments on or objections 

of the requested registration, as